{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:04:31Z","timestamp":1758672271603,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P-28183","W-1258"],"award-info":[{"award-number":["P-28183","W-1258"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.virol.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T08:06:26Z","timestamp":1626854786000},"page":"128-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Defining substrate selection by rhinoviral 2A proteinase through its crystal structure with the inhibitor zVAM.fmk"],"prefix":"10.1016","volume":"562","author":[{"given":"Karin M.","family":"Deutschmann-Olek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wyatt W.","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4471-821X","authenticated-orcid":false,"given":"Gustavo A.","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8865-5500","authenticated-orcid":false,"given":"Tim","family":"Skern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2021.07.008_bib1","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/pro.2807","article-title":"NMR analysis of the interaction of picornaviral proteinases Lb and 2A with their substrate eukaryotic initiation factor 4GII","volume":"24","author":"Aumayr","year":"2015","journal-title":"Protein Sci."},{"key":"10.1016\/j.virol.2021.07.008_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.virol.2017.08.020","article-title":"Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection","volume":"511","author":"Aumayr","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.virol.2021.07.008_bib3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jaip.2019.08.043","article-title":"Rhinovirus type in severe bronchiolitis and the development of asthma","volume":"8","author":"Bergroth","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.virol.2021.07.008_bib4","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.1021\/bi7010866","article-title":"NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (serotype 14): structural and dynamic comparison","volume":"46","author":"Bjorndahl","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.virol.2021.07.008_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12964-019-0451-2","article-title":"The multi-site docking protein Grb2-associated binder 1 (Gab1) enhances interleukin-6-induced MAPK-pathway activation in an SHP2-, Grb2-, and time-dependent manner","volume":"17","author":"Bongartz","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.virol.2021.07.008_bib6","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1021\/bi00485a009","article-title":"Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors","volume":"29","author":"Brady","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.virol.2021.07.008_bib7","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1128\/JVI.03541-12","article-title":"Conformational plasticity of the 2A proteinase from enterovirus 71","volume":"87","author":"Cai","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.07.008_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ng1583","article-title":"Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses","volume":"37","author":"Crowder","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.virol.2021.07.008_bib9","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1096\/fj.15-274829","article-title":"Enhanced enteroviral infectivity via viral protease-mediated cleavage of Grb2-associated binder 1","volume":"29","author":"Deng","year":"2015","journal-title":"Faseb. J."},{"key":"10.1016\/j.virol.2021.07.008_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-5793(04)00069-9","article-title":"Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase","volume":"560","author":"Deszcz","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virol.2021.07.008_bib11","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1128\/JVI.00612-06","article-title":"An antiviral peptide inhibitor that is active against picornavirus 2A proteinases but not cellular caspases","volume":"80","author":"Deszcz","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.07.008_bib12","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1038\/s41564-019-0551-1","article-title":"Enterovirus pathogenesis requires the host methyltransferase SETD3","volume":"4","author":"Diep","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.virol.2021.07.008_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.virol.2021.07.008_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archinte.163.4.487","article-title":"The economic burden of non-influenza-related viral respiratory tract infection in the United States","volume":"163","author":"Fendrick","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.virol.2021.07.008_bib15","doi-asserted-by":"crossref","first-page":"33200","DOI":"10.1074\/jbc.M304007200","article-title":"Human rhinovirus 2 2Apro recognition of eukaryotic initiation factor 4GI. Involvement of an exosite","volume":"278","author":"Foeger","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.07.008_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/iid3.206","article-title":"T-cell responses against rhinovirus species A and C in asthmatic and healthy children","volume":"6","author":"Gaido","year":"2018","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.virol.2021.07.008_bib17","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1128\/jvi.70.12.8444-8450.1996","article-title":"The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase","volume":"70","author":"Haghighat","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.07.008_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-4939-1571-2_10","article-title":"Proteases of human rhinovirus: role in infection","volume":"1221","author":"Jensen","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2021.07.008_bib19","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1107\/S0907444904026460","article-title":"Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions","volume":"60","author":"Krissinel","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.virol.2021.07.008_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/rmv.1883","article-title":"Enteroviral proteases: structure, host interactions and pathogenicity","volume":"26","author":"Laitinen","year":"2016","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2021.07.008_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/vim.2017.0152","article-title":"Prospective assessment of rhinovirus symptoms and species recurrence in children with and without an acute wheezing exacerbation","volume":"31","author":"Lethbridge","year":"2018","journal-title":"Viral Immunol."},{"key":"10.1016\/j.virol.2021.07.008_bib22","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.1021\/bi00080a033","article-title":"Purification of two picornaviral 2A proteinases: interaction with eIF-4 gamma and influence on in vitro translation","volume":"32","author":"Liebig","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.virol.2021.07.008_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr D Struct Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2021.07.008_bib24","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1093\/infdis\/jiu043","article-title":"Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication","volume":"210","author":"McKinlay","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2021.07.008_bib25","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1164\/rccm.201803-0575OC","article-title":"Rhinovirus species-specific antibodies differentially reflect clinical outcomes in health and asthma","volume":"198","author":"Megremis","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.virol.2021.07.008_bib26","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1099\/vir.0.051201-0","article-title":"Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues","volume":"94","author":"Neubauer","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2021.07.008_bib27","doi-asserted-by":"crossref","first-page":"28796","DOI":"10.1074\/jbc.M110.143404","article-title":"Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease","volume":"285","author":"Park","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.07.008_bib28","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1093\/emboj\/18.20.5463","article-title":"The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesis","volume":"18","author":"Petersen","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2021.07.008_bib29","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1073\/pnas.0602571103","article-title":"A common allosteric site and mechanism in caspases","volume":"103","author":"Scheer","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"year":"2015","series-title":"The PyMOL Molecular Graphics System","author":"Schrodinger","key":"10.1016\/j.virol.2021.07.008_bib30"},{"key":"10.1016\/j.virol.2021.07.008_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1473-3099(02)00277-3","article-title":"FDA panel rejects common cold treatment","volume":"2","author":"Senior","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2021.07.008_bib32","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3324\/haematol.2016.153767","article-title":"Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality","volume":"102","author":"Seo","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.virol.2021.07.008_bib33","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.232504","article-title":"Rhinovirus 2A is the key protease responsible for instigating the early block to gene expression in infected cells","volume":"133","author":"Smart","year":"2020","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.virol.2021.07.008_bib34","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1016\/j.febslet.2006.09.023","article-title":"Defining residues involved in human rhinovirus 2A proteinase substrate recognition","volume":"580","author":"Sousa","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virol.2021.07.008_bib35","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.47.2001847","article-title":"Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020","volume":"25","author":"Sullivan","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.virol.2021.07.008_bib36","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1128\/JVI.73.4.3467-3472.1999","article-title":"Eukaryotic initiation factor 4GII (eIF4GII), but not eIF4GI, cleavage correlates with inhibition of host cell protein synthesis after human rhinovirus infection","volume":"73","author":"Svitkin","year":"1999","journal-title":"J. Virol."},{"year":"2017","series-title":"Investigating the Mechanism of host Translation Shut off by human Rhinovirus 2A Proteinases. Master Thesis","author":"\u00dcz\u00fclmez","key":"10.1016\/j.virol.2021.07.008_bib37"},{"key":"10.1016\/j.virol.2021.07.008_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-4939-1571-2_9","article-title":"Capillary electrophoresis, gas-phase electrophoretic mobility molecular analysis, and electron microscopy: effective tools for quality assessment and basic rhinovirus research","volume":"1221","author":"Weiss","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2021.07.008_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.virol.2021.07.008_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jcv.2014.06.025","article-title":"The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease-a systematic review","volume":"61","author":"Zwaans","year":"2014","journal-title":"J. Clin. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682221001550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682221001550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:56:15Z","timestamp":1758588975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682221001550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":40,"alternative-id":["S0042682221001550"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2021.07.008","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining substrate selection by rhinoviral 2A proteinase through its crystal structure with the inhibitor zVAM.fmk","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}